IBD: Postoperative VTE prophylaxis in IBD

Nature Reviews Gastroenterology and Hepatology

Volumn 10, Issue 1, 2013, Pages 5-6

  Nguyen, Geoffrey C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL SURGERY; ADL DISABILITY; ANEMIA; ANESTHESIA; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING DISORDER; COLON RESECTION; COLON STENOSIS; CROHN DISEASE; DISEASE SEVERITY; DRUG USE; EMERGENCY SURGERY; ENTERITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SURGERY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MALNUTRITION; OBSERVATIONAL STUDY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOSIS PREVENTION; TREATMENT INDICATION; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM;

COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 84871958652     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.233     Document Type: Article

References (10)

1. Grainge, M. J., West, J. & Card, T. R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375, 657-663 (2010).
2. Nguyen, G. C. & Sam, J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am. J. Gastroenterol. 103, 2272-2280 (2008).
3. Sam, J. J., Bernstein, C. N., Razik, R., Thanabalan, R. & Nguyen, G. C. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Dig. Dis. Sci. http://dx.doi.org/10. 1007/s10620-012-2435-6.
4. Bergmann, J. F. et al. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb. Haemost. 103, 736-748 (2010).
5. Wallaert, J. B. et al. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis. Colon Rectum 55, 1138-1144 (2012).
6. Danese, S. et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am. J. Gastroenterol. 102, 174-186 (2007).
7. Scarpa, M. et al. Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough? World J. Surg. 34, 1629-1636 (2010).
8. Gould, M. K. et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141 (Suppl. 2), e227S-e277S (2012).
9. Shen, J., Ran, Z. H., Tong, J. L. & Xiao, S. D. Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis. Aliment. Pharmacol. Ther. 26, 653-663 (2007).
10. McLeod, R. S. et al. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann. Surg. 233, 438-444 (2001).